All enrolled individuals who obtained at the least just one dose of zosuquidar or placebo during induction have been monitored to the event of adverse occasions (439 individuals, 219 on zosuquidar and 210 on placebo). The commonest adverse gatherings ended up connected with the period of extended and considerable myelosuppression https://docetaxel13567.bligblogging.com/28573247/indicators-on-ly-3000328-you-should-know